BioTelemetry Inc (BEAT)

28.75
NASDAQ : Health Care
Prev Close 28.30
Day Low/High 28.05 / 29.00
52 Wk Low/High 14.72 / 34.00
Avg Volume 511.40K
Exchange NASDAQ
Shares Outstanding 28.66M
Market Cap 810.94M
EPS 1.90
P/E Ratio 17.47
Div & Yield N.A. (N.A)

Latest News

BEAT Crosses Above Average Analyst Target

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $28.67, changing hands for $28.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Noteworthy Thursday Option Activity: BEAT, OCN, CTL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in BioTelemetry Inc , where a total volume of 2,390 contracts has been traded thus far today, a contract volume which is representative of approximately 239,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 45.3% of BEAT's average daily trading volume over the past month, of 528,120 shares.

BioTelemetry, Inc. Reports First Quarter 2017 Financial Results

Company Reports Record Quarterly Revenue and Patient Volume

BioTelemetry, Inc. Issues Prospectus For Public Tender Offer To Acquire LifeWatch AG

LifeWatch Board of Directors Supports BioTelemetry Tender Offer

Commit To Buy BioTelemetry At $27, Earn 13% Annualized Using Options

Investors eyeing a purchase of BioTelemetry Inc shares, but cautious about paying the going market price of $30.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $27 strike, which has a bid at the time of this writing of $2.10.

BioTelemetry, Inc. Launches A Tender Offer To Acquire LifeWatch AG

Strengthens Remote Patient Monitoring Platform

The BEAT Goes on at BioTelemetry

The BEAT Goes on at BioTelemetry

BEAT is the ticker symbol for this health care name, which we think Sonny and Cher would love.

BioTelemetry, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results

Company Reports Record Results

BioTelemetry Reaches Analyst Target Price

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $25.00, changing hands for $25.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Sprint & BioTelemetry, Inc. Receive A 2017 IoT Evolution Business Impact Award

Award Recognizes Businesses that Deployed Successful IoT Solutions

BioTelemetry, Inc. Announces Acquisition Of Telcare's Remote Diabetes Management Platform

BioTelemetry, Inc. Announces Acquisition Of Telcare's Remote Diabetes Management Platform

Extends reach into rapidly expanding digital population health management market

Commit To Purchase BioTelemetry At $15, Earn 16.5% Annualized Using Options

Commit To Purchase BioTelemetry At $15, Earn 16.5% Annualized Using Options

Investors eyeing a purchase of BioTelemetry Inc stock, but cautious about paying the going market price of $16.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $15 strike, which has a bid at the time of this writing of $1.30.

BioTelemetry Breaks Below 200-Day Moving Average - Notable for BEAT

BioTelemetry Breaks Below 200-Day Moving Average - Notable for BEAT

In trading on Thursday, shares of BioTelemetry Inc crossed below their 200 day moving average of $15.67, changing hands as low as $15.25 per share. BioTelemetry Inc shares are currently trading off about 16.4% on the day.

BioTelemetry, Inc. Reports Third Quarter 2016 Financial Results

BioTelemetry, Inc. Reports Third Quarter 2016 Financial Results

Company Continues to Achieve Record Results

Buyers Get Picky About Bargains

Buyers Get Picky About Bargains

When stocks are pulling back then there are harder choices to make.

Shark Bites: Two Big Movers

Shark Bites: Two Big Movers

'If there are worries about the market topping out it isn't evident in [today's] price action.'

Shark Bites: Two Big Movers

Shark Bites: Two Big Movers

'If there are worries about the market topping out it isn't evident in [today's] price action.'

Ignore Market Jitters, Let Price Action Be the Guide

Ignore Market Jitters, Let Price Action Be the Guide

Equities are holding up well, despite concerns that good economic news increases the chances of a rate hike.

Shark Bites: Putting Cash to Work Isn't Easy

I may have to use an index play to get more money to work.

Shark Bites: No Market for Old Stock Pickers

Individual stock picks are much more difficult.

BioTelemetry, Vonage and TPI Composites Have Dipped

BioTelemetry, Vonage and TPI Composites Have Dipped

Ideally I'd like to buy a negative response to Janet Yellen tomorrow.